Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.53
-1.2%
$2.54
$2.07
$3.80
$77.51M0.6237,839 shs84,441 shs
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$0.77
-4.1%
$0.63
$0.29
$0.98
$18.57M0.7820,877 shs67,323 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.76
-0.2%
$4.62
$4.01
$9.33
$78.28M1.3204,178 shs54,878 shs
Zynex, Inc. stock logo
ZYXI
Zynex
$2.29
-3.4%
$2.26
$1.66
$10.62
$69.25M0.7162,620 shs453,880 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InspireMD, Inc. stock logo
NSPR
InspireMD
+4.49%+12.28%+4.49%-20.50%+1.19%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.00%+5.13%+37.74%+47.94%+28.75%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-1.45%+1.92%+7.19%-0.21%-15.43%
Zynex, Inc. stock logo
ZYXI
Zynex
-4.82%+3.04%+6.28%-67.13%-76.35%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
InspireMD, Inc. stock logo
NSPR
InspireMD
1.7323 of 5 stars
3.50.00.00.00.02.50.6
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
N/AN/AN/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.1008 of 5 stars
3.61.00.00.02.80.01.3
Zynex, Inc. stock logo
ZYXI
Zynex
2.7719 of 5 stars
3.20.00.00.01.52.53.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5077.87% Upside
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67145.10% Upside
Zynex, Inc. stock logo
ZYXI
Zynex
2.33
Hold$6.00162.01% Upside

Current Analyst Ratings Breakdown

Latest PETV, NSPR, SRTS, and ZYXI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
4/30/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$5.00 ➝ $4.00
4/30/2025
Zynex, Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $8.00
4/15/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $15.00
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform$11.00 ➝ $5.50
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
3/11/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $13.00
(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M11.03N/AN/A$1.83 per share1.38
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$1.05M17.75N/AN/A($0.03) per share-25.54
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$39.49M1.98$0.05 per share96.29$2.98 per share1.60
Zynex, Inc. stock logo
ZYXI
Zynex
$172.40M0.40$0.13 per share18.01$1.36 per share1.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
-$10.95M-$0.45N/AN/A-902.82%-4,813.07%-281.78%6/26/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1011.9020.70N/A15.90%12.60%11.38%8/14/2025 (Estimated)
Zynex, Inc. stock logo
ZYXI
Zynex
$9.73M-$0.2415.274.87N/A2.49%13.05%3.78%7/23/2025 (Estimated)

Latest PETV, NSPR, SRTS, and ZYXI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
4/28/2025Q1 2025
Zynex, Inc. stock logo
ZYXI
Zynex
-$0.24-$0.33-$0.09-$0.33$30.83 million$26.58 million
3/11/2025Q4 2024
Zynex, Inc. stock logo
ZYXI
Zynex
$0.09-$0.02-$0.11-$0.02$53.65 million$45.98 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.02
0.42
0.47
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
10.52
7.89
Zynex, Inc. stock logo
ZYXI
Zynex
1.66
3.94
3.15

Institutional Ownership

CompanyInstitutional Ownership
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
24.55%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Zynex, Inc. stock logo
ZYXI
Zynex
29.68%

Insider Ownership

CompanyInsider Ownership
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
10.84%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
Zynex, Inc. stock logo
ZYXI
Zynex
49.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
2024.23 million19.06 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.45 million14.85 millionOptionable
Zynex, Inc. stock logo
ZYXI
Zynex
77030.24 million15.25 millionOptionable

Recent News About These Companies

Here’s Why Zynex (ZYXI) Fell in Q1

New MarketBeat Followers Over Time

Media Sentiment Over Time

InspireMD stock logo

InspireMD NYSE:NSPR

$2.53 -0.03 (-1.17%)
Closing price 04:00 PM Eastern
Extended Trading
$2.56 +0.03 (+0.99%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

PetVivo stock logo

PetVivo NASDAQ:PETV

$0.77 -0.03 (-4.11%)
As of 11:29 AM Eastern

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.76 -0.01 (-0.21%)
Closing price 04:00 PM Eastern
Extended Trading
$4.78 +0.02 (+0.42%)
As of 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Zynex stock logo

Zynex NASDAQ:ZYXI

$2.29 -0.08 (-3.38%)
Closing price 04:00 PM Eastern
Extended Trading
$2.29 0.00 (0.00%)
As of 05:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.